The U.S. Food and Drug Administration (FDA) in late March approved the biologic medication certolizumab pegol (Cimzia), a tumor necrosis factor (TNF) inhibitor, to treat a newly defined condition called non-radiographic axial spondyloarthritis (nr-axSpA). Continue reading FDA Approves First Drug for Newly Defined Spinal Condition
Access to care for arthritis patients isn’t always a guarantee. All too often, seeing a rheumatologist includes traveling out of state because of the severe rheumatologist shortage. We are committed to closing this gap by offering fellowship grants to universities in underserved areas that offer innovative training programs. Continue reading Closing the Gap in the Nation’s Rheumatologist Shortage
If you have gout and rely on lesinurad (Zurampic) or lesinurad plus allopurinol (Duzallo), you’ll need to check with your doctor to find an alternative for managing the pain, swelling, redness and other symptoms of your disease. That’s because these two drugs have been pulled from the market. Continue reading Two Gout Drugs Removed From Market
The 15th annual scientific meeting of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) opens today in Louisville, Kentucky. Continue reading CARRA 2019 Annual Scientific Meeting
The Live Yes! Online Community has started a new, on-going series called Hot Topics. Each Hot Topic discussion will take place Monday through Friday and is a 5-day, limited-time special event. Hot Topics will cover just that – trending, in-demand topics featuring a subject matter expert moderator.
Hot Topics are meant to spark discussion and give Online Community users the opportunity to ask questions, share thoughts and get clarity around subjects that matter most. Recently we’ve featured discussions around medical marijuana and CBD oil, plus regenerative medicine and stem cells! Check back here for the most up-to-date schedule for all upcoming Hot Topics!
Upcoming Hot Topic Events:
April 22 – 26, 2019: Insurance Solutions-Happening now!
Ask the experts about your insurance hassles. They’ve got real-world advice and inside tips.
Featured Guest Experts:
Christina Reeg, Heidi Barrett and Anna Hyde
May 6 – 10, 2019: Opioids
The Online Community will feature a new Hot Topic event every other week for the duration of the year. At the end of each week, the discussion is concluded, and the Hot Topic forum is taken down. Be sure to visit the Online Community during Hot Topic events so you don’t miss out!
The Live Yes! Online Community is an online forum that allows members connect, share and chat with others in a digital space. Currently there are discussion forums dedicated to rheumatoid arthritis, psoriatic arthritis, osteoarthritis, other types of arthritis, families affected by juvenile arthritis (JA), advocacy and a popular one for fun, off-topic talk. There is also a special forum called Ask the Professionals, where a rheumatologist and orthopedic surgeon answer community users’ questions.
One of our users recently noted, “The Live Yes! Online Community is a much needed resource since many of us aren’t able to travel to in-person events. This allows us to communicate with others, share stories and experiences, and get our questions answered by health care providers, all from the comfort of our home!”
Registration in the Live Yes! Online Community is free, and forums are moderated by trained volunteers. Sign up today and join us!
Dr. Andrea Knight, lead investigator, will present “Engaging Patients and Parents to Improve Mental Health for Youth With Rheumatologic Disease” at the 13th International Congress on Systemic Lupus Erythematosus in San Francisco, April 5-8. The results of this study will also appear in the April 2019 issue of Lupus Science & Medicine. Continue reading Improving Mental Health for Kids With Juvenile Arthritis
In 2016, the Osteoarthritis Research Society International (OARSI) reported that osteoarthritis (OA) is the third most prevalent condition causing disability globally. Currently, there is no cure for OA, which is the most prevalent form of arthritis both in the U.S. and worldwide. Continue reading Our Reach Expands With Global Osteoarthritis Management
The Arthritis Foundation is pleased to announce the recipients of the most recent round of Arthritis Foundation–CARRA Large and Small Grants! The CARRA (Childhood Arthritis & Rheumatology Research Alliance) members below were recently awarded one-year grants with project dates of April 1, 2019 – March 31, 2020. Continue reading Arthritis Foundation-CARRA Grant Awardees Announced
Are you considering making a planned gift to the Arthritis Foundation, but don’t want to go through the time and expense to make changes to your existing estate plans? Don’t fret. It’s probably easier than you think.
In this video, Aric Grooms, Senior Director of Planned Giving for the Arthritis Foundation, discusses just how simply those changes can oftentimes be made. For more information, contact our Planned Giving Department at 866-528-8687, or at firstname.lastname@example.org.
Dr. Sanja Arandjelovic has been studying inflammation and arthritis for a while – specifically, how a gene called ELMO1 is related to arthritis symptoms in mice. In 2010, the Arthritis Foundation awarded Dr. Arandjelovic the Philip S. Maaram Esq. Research (Planned Giving) 3-year grant for a project that studied cell enzymes related to joint inflammation in rheumatoid arthritis (RA) in mice.
During this study, Dr. Arandjelovic worked with Dr. Kodi Ravichandran and his research team at the University of Virginia on a related project, examining the process of joint inflammation in RA. Their work may provide clues to why the pain flare-ups associated with RA occur – and lead to new treatments.